Atrial fibrillation trials in Chile

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

  Where

  Concepción, Independencia, Providencia, San Bernardo, San Miguel, Santiago, Talcahuano, Temuco, Viña del Mar

  Age

  65 years and over

  People

  2,500 worldwide

  Run by

  Anthos Therapeutics, Inc.

  See details and how to joinNCT05712200 · EU 2023-503224-66-00